ARUK 2018 | What are the benefits of collaborating with the Drug Discovery Institute?
The Alzheimer’s Research UK (ARUK) Drug Discovery Institute (DDI) works with researchers on various projects, such as the development of screening processes to identify novel targets and recognize compounds that may be developed into novel drugs. The DDI also works with pharmaceutical companies to provide a link between academia and ongoing clinical research, with aims to further progress the discovery of new drugs targeting neurodegenerative diseases. Here, Amy Monaghan, from the UCL DDI, London, UK, speaking from the ARUK Conference 2018, held in London, UK, highlights the importance of finding a treatment that has the potential to slow the progression of dementia.
Get great new content delivered to your inboxSign up